Differential counts of 32Dcl3 and 32D/ε cells treated with interleukin 3, granulocyte colony-stimulating factor, or both
| Cells . | IL-3 . | G-CSF . | IL-3 + G-CSF . | ||||
|---|---|---|---|---|---|---|---|
| Day 4 . | Day 7 . | Day 10 . | Day 14 . | Day 4 . | Day 7 . | ||
| 32Dcl3 | |||||||
| Myeloblasts | 96.6 ± 1.5 | 87.0 ± 3.6 | 3.7 ± 4.0 | 3.3 ± 1.5 | 0.3 ± 0.6 | 92.0 ± 2.6 | 93.7 ± 3.1 |
| Myelocytes | 5.0 ± 2.0 | 11.3 ± 3.5 | 72.6 ± 8.0 | 29.0 ± 3.6 | 21.0 ± 5.6 | 8.0 ± 2.6 | 6.3 ± 3.1 |
| Band (seg) | 0 ± 0 | 2.3 ± 1.2 | 23.7 ± 11.1 | 67.7 ± 4.6 | 78.3 ± 5.5 | 0 ± 0 | 0 ± 0 |
| 32D/ε | |||||||
| Myeloblasts | 85.0 ± 7.0 | 1.0 ± 1.0 | 0 ± 0 | — | — | 83.7 ± 3.2 | 83.7 ± 6.0 |
| Myelocytes | 11.0 ± 5.3 | 25.7 ± 4.0 | 21.0 ± 3.6 | — | — | 9.3 ± 2.1 | 11.3 ± 3.2 |
| Band (seg) | 4.0 ± 2.6 | 73.3 ± 3.8 | 79.0 ± 3.6 | — | — | 7.0 ± 3.6 | 5.0 ± 3.5 |
| Cells . | IL-3 . | G-CSF . | IL-3 + G-CSF . | ||||
|---|---|---|---|---|---|---|---|
| Day 4 . | Day 7 . | Day 10 . | Day 14 . | Day 4 . | Day 7 . | ||
| 32Dcl3 | |||||||
| Myeloblasts | 96.6 ± 1.5 | 87.0 ± 3.6 | 3.7 ± 4.0 | 3.3 ± 1.5 | 0.3 ± 0.6 | 92.0 ± 2.6 | 93.7 ± 3.1 |
| Myelocytes | 5.0 ± 2.0 | 11.3 ± 3.5 | 72.6 ± 8.0 | 29.0 ± 3.6 | 21.0 ± 5.6 | 8.0 ± 2.6 | 6.3 ± 3.1 |
| Band (seg) | 0 ± 0 | 2.3 ± 1.2 | 23.7 ± 11.1 | 67.7 ± 4.6 | 78.3 ± 5.5 | 0 ± 0 | 0 ± 0 |
| 32D/ε | |||||||
| Myeloblasts | 85.0 ± 7.0 | 1.0 ± 1.0 | 0 ± 0 | — | — | 83.7 ± 3.2 | 83.7 ± 6.0 |
| Myelocytes | 11.0 ± 5.3 | 25.7 ± 4.0 | 21.0 ± 3.6 | — | — | 9.3 ± 2.1 | 11.3 ± 3.2 |
| Band (seg) | 4.0 ± 2.6 | 73.3 ± 3.8 | 79.0 ± 3.6 | — | — | 7.0 ± 3.6 | 5.0 ± 3.5 |
Values are the mean ± SD percentages of cells from 3 independent experiments. Myelocytes includes promyelocytes, myelocytes, and metamyelocytes.
G-CSF, granulocyte colony-stimulating factor; IL-3, interleukin-3; band (seg), band and segmented neutrophils.